PathAI is a leader in the field of AI-powered pathology, dedicated to transforming patient outcomes by harnessing the power of AI. Its core mission revolves around enhancing the accuracy of diagnoses and the effectiveness of disease treatments, particularly in critical areas like cancer.
PathAI's pioneering spirit is evident through its breakthroughs, exemplified by innovations such as the AIM-HER2 Breast Cancer algorithm. This tool automates HER2 scoring and introduces a novel approach with additive multiple instance learning (aMIL) heatmaps, offering insights into scoring mechanisms. Additionally, PathAI's PathExplore panel of human interpretable features (HIFs) fosters collaborative research, thus enhancing understanding of the tumor microenvironment.
As the company moves forward, it is poised to continue shaping the landscape of AI-powered pathology, driving advancements in medical research, diagnostics, and drug development, while upholding its central mission to improve patient well-being.
Steph
Company Specialist at Welcome to the Jungle